Collegium Pharmaceutical Stock Five Year Return
COLL Stock | USD 37.30 0.28 0.76% |
Collegium Pharmaceutical fundamentals help investors to digest information that contributes to Collegium Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Collegium Stock. The fundamental analysis module provides a way to measure Collegium Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Collegium Pharmaceutical stock.
Collegium | Five Year Return |
Collegium Pharmaceutical Company Five Year Return Analysis
Collegium Pharmaceutical's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Collegium Five Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Collegium Pharmaceutical is extremely important. It helps to project a fair market value of Collegium Stock properly, considering its historical fundamentals such as Five Year Return. Since Collegium Pharmaceutical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Collegium Pharmaceutical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Collegium Pharmaceutical's interrelated accounts and indicators.
Click cells to compare fundamentals
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
Collegium Return On Tangible Assets
Return On Tangible Assets |
|
According to the company disclosure, Collegium Pharmaceutical has a Five Year Return of 0.0%. This indicator is about the same for the Pharmaceuticals average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Collegium Pharmaceutical Current Valuation Drivers
We derive many important indicators used in calculating different scores of Collegium Pharmaceutical from analyzing Collegium Pharmaceutical's financial statements. These drivers represent accounts that assess Collegium Pharmaceutical's ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Collegium Pharmaceutical's important valuation drivers and their relationship over time.
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Market Cap | 688.5M | 689.2M | 652.6M | 1.0B | 934.7M | 981.4M | |
Enterprise Value | 540.1M | 781.7M | 724.9M | 1.5B | 1.3B | 1.4B |
Collegium Fundamentals
Return On Equity | 0.25 | ||||
Return On Asset | 0.1 | ||||
Profit Margin | 0.09 % | ||||
Operating Margin | 0.41 % | ||||
Current Valuation | 1.55 B | ||||
Shares Outstanding | 32.71 M | ||||
Shares Owned By Insiders | 1.41 % | ||||
Shares Owned By Institutions | 98.59 % | ||||
Number Of Shares Shorted | 6.99 M | ||||
Price To Earning | 28.80 X | ||||
Price To Book | 5.98 X | ||||
Price To Sales | 2.06 X | ||||
Revenue | 566.77 M | ||||
Gross Profit | 345.74 M | ||||
EBITDA | 331.83 M | ||||
Net Income | 48.16 M | ||||
Cash And Equivalents | 122.72 M | ||||
Cash Per Share | 3.60 X | ||||
Total Debt | 674.28 M | ||||
Debt To Equity | 3.82 % | ||||
Current Ratio | 0.99 X | ||||
Book Value Per Share | 6.13 X | ||||
Cash Flow From Operations | 274.75 M | ||||
Short Ratio | 14.42 X | ||||
Earnings Per Share | 1.29 X | ||||
Target Price | 40.0 | ||||
Number Of Employees | 197 | ||||
Beta | 1.05 | ||||
Market Capitalization | 1.21 B | ||||
Total Asset | 1.14 B | ||||
Retained Earnings | (233.19 M) | ||||
Working Capital | 79.69 M | ||||
Current Asset | 96.88 M | ||||
Current Liabilities | 8.43 M | ||||
Net Asset | 1.14 B |
About Collegium Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Collegium Pharmaceutical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Collegium Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Collegium Pharmaceutical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Collegium Pharmaceutical
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Collegium Pharmaceutical position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Collegium Pharmaceutical will appreciate offsetting losses from the drop in the long position's value.Moving together with Collegium Stock
0.81 | A | Agilent Technologies Financial Report 28th of May 2024 | PairCorr |
0.74 | CRL | Charles River Labora Financial Report 9th of May 2024 | PairCorr |
Moving against Collegium Stock
0.59 | GRFS | Grifols SA ADR | PairCorr |
0.54 | GNFT | Genfit | PairCorr |
0.49 | SHC | Sotera Health | PairCorr |
The ability to find closely correlated positions to Collegium Pharmaceutical could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Collegium Pharmaceutical when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Collegium Pharmaceutical - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Collegium Pharmaceutical to buy it.
The correlation of Collegium Pharmaceutical is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Collegium Pharmaceutical moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Collegium Pharmaceutical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Collegium Pharmaceutical can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Collegium Pharmaceutical Piotroski F Score and Collegium Pharmaceutical Altman Z Score analysis. For more information on how to buy Collegium Stock please use our How to buy in Collegium Stock guide.You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Complementary Tools for Collegium Stock analysis
When running Collegium Pharmaceutical's price analysis, check to measure Collegium Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Collegium Pharmaceutical is operating at the current time. Most of Collegium Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Collegium Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Collegium Pharmaceutical's price. Additionally, you may evaluate how the addition of Collegium Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
CEOs Directory Screen CEOs from public companies around the world | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Fundamental Analysis View fundamental data based on most recent published financial statements |
Is Collegium Pharmaceutical's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Collegium Pharmaceutical. If investors know Collegium will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Collegium Pharmaceutical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 51.976 | Earnings Share 1.29 | Revenue Per Share 16.797 | Quarterly Revenue Growth 0.155 | Return On Assets 0.1028 |
The market value of Collegium Pharmaceutical is measured differently than its book value, which is the value of Collegium that is recorded on the company's balance sheet. Investors also form their own opinion of Collegium Pharmaceutical's value that differs from its market value or its book value, called intrinsic value, which is Collegium Pharmaceutical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Collegium Pharmaceutical's market value can be influenced by many factors that don't directly affect Collegium Pharmaceutical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Collegium Pharmaceutical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Collegium Pharmaceutical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Collegium Pharmaceutical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.